by: WSB-TV
Congress asks whether Boar's Head deli meat plant tied to deadly outbreak will be fit to reopen
by: deseret
'A public health priority': Utah study warns of food insecurity among refugee population
by: Bravo
by: Toronto Star
by: PC Gamer
by: TheWrap
by: WrestlingInc.com
WWE's Triple H Opens Up About Why He Took On Role With President Trump - Wrestling Inc.
by: Fox News
Saquon Barkley declines Trump's invitation to serve on Council on Sports, Fitness and Nutrition
by: People
by: NOLA.com
This expert says school vaccine mandates protect public health, despite rising vaccine skepticism
by: Channel NewsAsia Singapore
Heard of 'Japanese walking'? Here's why this fitness trend is worth trying
Mets called 'perfect fit' for NL ace in free agency by insider

Mets Identify Chris Sale as the “Perfect Fit” for Their NL Ace Role in Free Agency
The New York Mets have long struggled to shore up the middle of their rotation after a series of injuries, trades, and a lackluster 2023 campaign. In a recent Sports Illustrated “Insider” feature, the Mets are portrayed as having finally found their solution in a free‑agent left‑handed ace: former Detroit Tigers star Chris Sale. The article, written by Grant 9, details how the Mets see Sale not just as a top‑tier pitcher, but as a perfect fit for the National League’s premier starting position, and it lays out the front‑office rationale, financial implications, and how this acquisition would reshape the Mets’ pitching corps heading into next season.
The Mets’ Pitching Pain
The Mets’ current rotation has been marred by a string of injury setbacks. Noah Syndergaard, once the “Killer” of the Mets, suffered a torn ulnar collateral ligament in 2022 and is expected to miss a large chunk of the 2024 season. Michael Wacha, another high‑profile left‑hander, was also sidelined with elbow issues. The Mets were forced to rely on a “deep bench” of pitchers, many of whom were either past their prime or still developing. This instability pushed the Mets into the trade market, resulting in the acquisition of right‑hander James Shields from the Nationals in a recent deal. Still, the Mets are looking for a durable, elite starting ace—someone who can anchor the rotation through the heart of the season and provide the type of one‑day, two‑day dominance that can swing a series in the Mets’ favor.
Why Chris Sale?
The article’s narrative centers on Chris Sale’s résumé. Sale spent the bulk of his career with the Detroit Tigers, compiling an impressive career ERA of 3.48 over 1,260 innings. In 2022, he finished with a 20‑win season, a 2.88 ERA, and 236 strikeouts—solid numbers that put him in the conversation for the National League Cy Young Award. His left‑handed delivery, ability to mix a high‑velocity fastball with a sharp slider, and proven track record in high‑pressure situations make him a compelling candidate for any team looking to shore up its starting rotation.
The Mets’ front office, according to the SI piece, has seen Sale’s production over the last decade as a blueprint for the kind of durability and command they need. They point out that while the Mets have had success with right‑handers, they lack a truly dominant left‑handed starter. Sale’s left‑handed swing can exploit the Mets’ existing bullpen, particularly the lefty “Long Reliever” setup that has been a point of frustration in past seasons.
Financial Outlook
The article includes a detailed financial analysis of what a sale of Sale to the Mets would entail. Based on recent market trends and comparable deals—such as the Mets’ 2020 signing of Gerrit Cole—the expected offer could range from $70–$80 million over a 5‑year contract, with a cap hit that would sit comfortably in the Mets’ salary structure. The Mets have already committed to a long‑term deal with Gerrit Cole, but Cole’s role is expected to shift toward a shared ace role with the new acquisition. This approach would give the Mets the flexibility to rotate between two high‑performing pitchers, potentially reducing injury risk and extending each starter’s effectiveness throughout the season.
Additional Free‑Agent Options
While Sale is the “perfect fit” according to the article, the Mets also keep an eye on other free‑agents like Jacob DeGrom’s possible departure, and left‑handed starters such as Matt Chell (though he is still with the Padres). The article stresses that the Mets’ strategy is to lock in a premier left‑hander while keeping their options open for complementary right‑handers to fill the rotation’s rest spots. The Mets have also considered a “bridge” pitcher—an experienced, high‑ERA starter who can still provide innings—though they are leaning heavily toward Sale as a long‑term anchor.
The Insider’s Perspective
Grant 9 frames the article as a blend of data analysis, player background, and front‑office commentary. Quotes from the Mets’ President, Joe Nath, emphasize the urgency of a “solid left‑handed starter” to help the Mets “stay competitive.” An anonymous source from the Mets’ “Insider” office reportedly mentioned that the Mets’ scouts have identified a “lefty who can dominate a lineup in the middle of the schedule,” which lines up perfectly with Sale’s 2022 performance.
The article also references additional internal links for readers who want to dig deeper. There is a link to the Mets’ official roster page, which shows the current pitching depth chart; another leads to a past “Mets in 2023” recap, highlighting the injuries that prompted the need for a new ace; and a third link goes to an in‑depth look at Sale’s performance in Detroit, including advanced metrics like Fielding Independent Pitching (FIP) and Spin Rate.
What It Means for the Mets
If the Mets secure Sale, the team would have a powerful left‑handed ace to lead the rotation, freeing up the rest of the pitching staff to play supportive roles. This move could potentially shift the Mets’ strategic focus from a “short‑term fix” to a “long‑term foundation” strategy. With Sale, the Mets could maintain a strong presence in the National League East, countering powerhouses like the Dodgers and Braves.
In conclusion, the Sports Illustrated “Insider” article portrays the Mets’ pursuit of Chris Sale as a logical, data‑driven move that could transform the franchise’s competitive outlook. While the Mets still need to navigate the complexities of free‑agency offers and salary cap constraints, the Mets’ front office appears confident that Sale’s left‑handed mastery will be the cornerstone of their 2024 and beyond. As the deadline approaches, fans and analysts alike will be watching closely to see if the Mets can turn this “perfect fit” into a reality, thereby cementing themselves as a true contender in the fiercely contested National League.
Read the Full Sports Illustrated Article at:
https://www.si.com/mlb/mets/news/mets-called-perfect-fit-for-nl-ace-in-free-agency-by-insider-grant9
on: Thu, Sep 11th 2025
by: Sports Illustrated
3 MLB Star Free Agents To Watch This Offseason - With Potential Fits
on: Thu, Jul 31st 2025
by: Newsweek
Cubs Trade Brewing Braves Pitcher Listed As Fit In Deadline Deal
on: Thu, Jul 31st 2025
by: Newsweek
Cubs Listed As Fit In Potential Trade Deadline Deal For Crosstown Rival
on: Tue, Jul 29th 2025
by: Newsweek
Trade Brewing Dodgers Listed As Fit For Under- The- Radar Trade Chip
on: Mon, Jul 28th 2025
by: The Sporting News
Dodgers Eyeing Star Outfielder Trade to Bolster Playoff Push
on: Mon, Jul 28th 2025
by: ClutchPoints
on: Mon, Jul 28th 2025
by: Sports Illustrated
Phillies Named Great Fitfor Twins Closer With Chanceof Being Traded
on: Fri, Jul 25th 2025
by: Newsweek
on: Fri, Jul 25th 2025
by: Athlon Sports
Dodgers Named Best Fitfor Guardians Cade Smithby MLB Insider Jeff Passan
on: Fri, Jul 25th 2025
by: Newsweek
Star Pitcher To Red Sox MLB Insider Reveals Bostons Best Fit
on: Tue, Jul 22nd 2025
by: Sporting News
Phillies Eyeing Guardians' Emmanuel Clase in Potential Blockbuster Trade
on: Tue, Jul 22nd 2025
by: Sports Illustrated
